- Product NDC
- 64661-711
- 11-digit product format
- 646610711
- Labeler code
- 64661
- Product ID
- 64661-711_7da9c8a9-53bc-4964-b409-facfc14f51ba
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- leucovorin, folic acid, levomefolate magnesium, ferrous cysteine glycinate, 1,2-docosahexanoyl-sn-glycero-3-phosphoserine calcium, 1,2-icosapentoyl-sn-glycero-3-phosphoserine calcium, phosphatidyl serine, pyridoxal 5-phosphate, flavin adenine dinucleotide, nadh, cobamamide, cocarboxylase (thiamine pyrophosphate), magnesium ascorbate, zinc ascorbate, magnesium l-threonate and betaine
- Dosage form
- CAPSULE, DELAYED RELEASE PELLETS
- Route
- ORAL
- Labeler
- Jaymac Pharma
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketing start
- 2011-08-12
- Marketing end
- 0000-00-00
- Substance
- 1,2-DOCOSAHEXANOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM; 1,2-ICOSAPENTOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM; BETAINE; CITRIC ACID MONOHYDRATE; COBAMAMIDE; COCARBOXYLASE; FERROUS CYSTEINE GLYCINATE; FLAVIN ADENINE DINUCLEOTIDE; FOLIC ACID; LEUCOVORIN; LEVOMEFOLATE MAGNESIUM; MAGNESIUM ASCORBATE; MAGNESIUM L-THREONATE; NADH; PHOSPHATIDYL SERINE; PYRIDOXAL PHOSPHATE ANHYDROUS; SODIUM CITRATE; ZINC ASCORBATE
- Active strength
- 6 mg/1; ug/1; ug/1; mg/1; ug/1; ug/1; mg/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; ug/1; mg/1; ug/1; mg/1; mg/1
- Pharmacologic classes
- Acidifying Activity [MoA], Anti-coagulant [EPC], Ascorbic Acid [CS], Ascorbic Acid [CS], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Folate Analog [EPC], Folic Acid [CS], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Methylating Activity [MoA], Methylating Agent [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Vitamin C [EPC], Vitamin C [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record